Pay in 4 interest-free payments of $7.10 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Targeting mitochondrial quality control for diabetic cardiomyopathy: therapeutic potential of hypoglycemic drugs
The samples were drawn with anticoagulant (EDTA, Ethylenediaminetetraacetic acid), stored at 4 C, and analyzed within one hour
Peroxisome proliferator-activated receptors and caloric restriction-common pathways affecting metabolism, health, and longevity
These findings support current guideline recommendations from the American Diabetes Association (ADA) and the European Society of Cardiology endorsing GLP-1 RAs and/or SGLT2 inhibitors as first-line therapies for patients with type 2 diabetes and established CVD
US$ 22.70
US$ 22.78
US$ 29.36
US$ 26.32
US$ 28.52
US$ 22.19
